Nuveen Asset Management, LLC - IMMUNITYBIO INC ownership

IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 143 filers reported holding IMMUNITYBIO INC in Q4 2021. The put-call ratio across all filers is 4.28 and the average weighting 0.0%.

Quarter-by-quarter ownership
Nuveen Asset Management, LLC ownership history of IMMUNITYBIO INC
ValueSharesWeighting
Q3 2023$806,601
-32.5%
477,279
+11.1%
0.00%
Q2 2023$1,194,636
+272647.9%
429,725
+78.6%
0.00%
Q1 2023$438
-88.6%
240,585
-3.3%
0.00%
-100.0%
Q4 2022$3,826
-99.7%
248,898
-7.8%
0.00%0.0%
Q3 2022$1,342,000
+31.7%
269,983
-1.4%
0.00%
Q2 2022$1,019,000
-34.8%
273,838
-1.8%
0.00%
-100.0%
Q1 2022$1,564,000
-42.6%
278,720
-37.8%
0.00%0.0%
Q4 2021$2,726,000
+5.0%
448,278
+68.2%
0.00%0.0%
Q3 2021$2,595,000
+49.7%
266,436
-53.9%
0.00%0.0%
Q2 2021$1,734,000577,9000.00%
Other shareholders
IMMUNITYBIO INC shareholders Q4 2021
NameSharesValueWeighting ↓
Winning Points Advisors, LLC 251,556$1,387,0001.70%
ORACLE INVESTMENT MANAGEMENT INC 315,322$1,567,0000.89%
HARBOURVEST PARTNERS LLC 335,709$1,668,0000.54%
ALLEN HOLDING INC /NY 687,571$3,417,0000.54%
MERIDIAN INVESTMENT COUNSEL INC. 96,433$479,0000.21%
SHEETS SMITH WEALTH MANAGEMENT 207,926$1,033,0000.17%
Clearwater Capital Advisors, LLC 185,911$924,0000.13%
WEALTH EFFECTS LLC 28,500$142,0000.09%
Virtus ETF Advisers LLC 35,048$174,0000.07%
Vident Investment Advisory, LLC 195,127$969,0000.03%
View complete list of IMMUNITYBIO INC shareholders